fluoxetine has been researched along with Migraine Disorders in 24 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study is the first double-blind placebo-controlled trial of fluoxetine for chronic daily headache (CDH) and migraine." | 9.07 | Double-blind trial of fluoxetine: chronic daily headache and migraine. ( Lake, AE; Saper, JR; Silberstein, SD; Winters, ME, 1994) |
| "This study is the first double-blind placebo-controlled trial of fluoxetine for chronic daily headache (CDH) and migraine." | 5.07 | Double-blind trial of fluoxetine: chronic daily headache and migraine. ( Lake, AE; Saper, JR; Silberstein, SD; Winters, ME, 1994) |
| "Amitriptyline was dosed as follows: 8 mg/day for 6 days, 8 mg twice a day for 6 days, 20 mg/day for 6 days, and 20 mg twice a day for 45 days." | 2.70 | Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. ( Alves, LA; Barbosa, JS; Krymchantowski, AV; Silva, MT, 2002) |
| "Sixty-five patients needing migraine prophylaxis were recruited into a phase II, double-blind, placebo-controlled trial." | 2.69 | S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study. ( Ahmed, F; Findley, LJ; MacGregor, EA; Steiner, TJ; Wilkinson, M, 1998) |
| "The duration of the therapy of migraine between the attacks was 12 weeks." | 2.69 | [A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period]. ( Amelin, AV; Gonchar, MA; Korenko, LA; Skoromets, AA; Tumelevich, BCh, 2000) |
| "Fluoxetine appears to be a safe and effective drug for migraine prophylaxis, and deserves further therapeutic trials with larger groups for longer periods of time." | 2.67 | Fluoxetine prophylaxis of migraine. ( Adly, C; Chesson, A; Straumanis, J, 1992) |
| "Migraine is affected by fluctuating estrogen levels so it is not surprising that the perimenopause is a time of peak rate of change of migraine prevalence in women." | 2.48 | Perimenopausal migraine in women with vasomotor symptoms. ( MacGregor, EA, 2012) |
| "The association of migraine and depression has been confirmed in numerous studies and it has been suggested that both diseases influence each other in a bidirectional way." | 2.44 | [A clinical challenge. Pragmatic treatment of migraine and concomitant depression]. ( Jürgens, TP; Koch, HJ; Leinisch, E, 2008) |
| "Major depression and migraine are commonly comorbid." | 1.30 | Co-administration of fluoxetine and sumatriptan: the Canadian experience. ( Joffe, RT; Sokolov, ST, 1997) |
| "Serotonin syndrome is the result of the drug interaction that enhances serotonergic tone in the central nervous system." | 1.30 | Serotonin syndrome presenting with migrainelike stroke. ( Molaie, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 13 (54.17) | 18.2507 |
| 2000's | 9 (37.50) | 29.6817 |
| 2010's | 2 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, AH | 1 |
| Kearney, T | 1 |
| Jabre, MG | 1 |
| Shahidi, GA | 1 |
| Bejjani, BP | 1 |
| MacGregor, EA | 2 |
| Krymchantowski, AV | 1 |
| Silva, MT | 1 |
| Barbosa, JS | 1 |
| Alves, LA | 1 |
| Akarachkova, ES | 1 |
| Tabeeva, GR | 1 |
| Volkova, ZI | 1 |
| Dlusskaia, IG | 1 |
| Striuk, RI | 1 |
| Veĭn, AM | 1 |
| Ignatov, IuD | 1 |
| Skoromets, AA | 2 |
| Amelin, AV | 2 |
| Finfgeld, DL | 1 |
| Bonetto, N | 1 |
| Santelli, L | 1 |
| Battistin, L | 1 |
| Cagnin, A | 1 |
| Jürgens, TP | 1 |
| Leinisch, E | 1 |
| Koch, HJ | 1 |
| Evans, RW | 1 |
| Saper, JR | 2 |
| Silberstein, SD | 2 |
| Lake, AE | 2 |
| Winters, ME | 2 |
| Szabo, CP | 1 |
| Larson, EW | 1 |
| Petkov, VD | 1 |
| Belcheva, S | 1 |
| Konstantinova, E | 1 |
| Joffe, RT | 1 |
| Sokolov, ST | 1 |
| Molaie, M | 1 |
| Steiner, TJ | 1 |
| Ahmed, F | 1 |
| Findley, LJ | 1 |
| Wilkinson, M | 1 |
| Boon, F | 1 |
| Oguzhanoglu, A | 1 |
| Sahiner, T | 1 |
| Kurt, T | 1 |
| Akalin, O | 1 |
| Korenko, LA | 1 |
| Tumelevich, BCh | 1 |
| Gonchar, MA | 1 |
| Petitto, JM | 1 |
| Mundle, LB | 1 |
| Nagy, BR | 1 |
| Evans, DL | 1 |
| Golden, RN | 1 |
| Adly, C | 1 |
| Straumanis, J | 1 |
| Chesson, A | 1 |
4 reviews available for fluoxetine and Migraine Disorders
| Article | Year |
|---|---|
Perimenopausal migraine in women with vasomotor symptoms.
Topics: Amines; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Estrogens; Female; Fluoxetine; Ga | 2012 |
[Current views on migraine and anti-migraine preparations].
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Amitriptyline; Analgesics; Analgesics, No | 2003 |
Serotonin syndrome and the use of SSRIs.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Therapy, Combination; Fem | 2004 |
[A clinical challenge. Pragmatic treatment of migraine and concomitant depression].
Topics: Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Antidepressive Ag | 2008 |
7 trials available for fluoxetine and Migraine Disorders
| Article | Year |
|---|---|
Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Constipation; Double-Blind Method; Drug Therapy, | 2002 |
Fluoxetine and migraine: comparison of double-blind trials.
Topics: Chronic Disease; Double-Blind Method; Fluoxetine; Headache; Humans; Migraine Disorders; Multivariate | 1995 |
Double-blind trial of fluoxetine: chronic daily headache and migraine.
Topics: Adult; Affect; Chronic Disease; Double-Blind Method; Female; Fluoxetine; Headache; Humans; Male; Mid | 1994 |
S-fluoxetine in the prophylaxis of migraine: a phase II double-blind randomized placebo-controlled study.
Topics: Adult; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Migraine Disorders; Selec | 1998 |
Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches.
Topics: Adult; Amitriptyline; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Administration S | 1999 |
[A comparative efficiency of amitriptyline, fluoxetine and maprotiline in prevention of migraine in attack-free period].
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Analgesics, Non-Narcotic; Female; | 2000 |
Fluoxetine prophylaxis of migraine.
Topics: Double-Blind Method; Female; Fluoxetine; Humans; Male; Migraine Disorders; Pilot Projects | 1992 |
13 other studies available for fluoxetine and Migraine Disorders
| Article | Year |
|---|---|
Lack of impairment due to confirmed codeine use prior to a motor vehicle accident: role of pharmacogenomics.
Topics: Accidents, Traffic; Analgesics, Opioid; Bupropion; Codeine; Cytochrome P-450 CYP2D6; Dopamine Uptake | 2013 |
Probable fluoxetine-induced carotidynia.
Topics: Adult; Carotid Artery Diseases; Fluoxetine; Humans; Male; Migraine Disorders; Neck Pain; Selective S | 2009 |
[Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Citalopram; Diagnostic and Statistical Manual of Men | 2003 |
Serotonin syndrome and rhabdomyolysis induced by concomitant use of triptans, fluoxetine and hypericum.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypericum; Migraine Disorders; Rhabdom | 2007 |
Triptans and serotonin syndrome.
Topics: Adult; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hypericum; Migraine Disorders; Rhabdom | 2008 |
Fluoxetine and sumatriptan: possibly a counterproductive combination.
Topics: Acute Disease; Adult; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Flu | 1995 |
Migraine with typical aura associated with fluoxetine therapy: case report.
Topics: Agoraphobia; Fluoxetine; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Panic | 1993 |
Anxiolytic effects of dotarizine, a possible antimigraine drug.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Benzhydryl Compounds; Exploratory Behavior; Fluoxetine; Male; | 1995 |
Co-administration of fluoxetine and sumatriptan: the Canadian experience.
Topics: Canada; Depression; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Migraine Disor | 1997 |
Serotonin syndrome presenting with migrainelike stroke.
Topics: Adult; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Clomipramine; Confusi | 1997 |
Cyproheptadine and SSRIs.
Topics: Adolescent; Cyproheptadine; Depressive Disorder; Drug Administration Schedule; Drug Interactions; Fe | 1999 |
S-fluoxetine.
Topics: Clinical Trials, Phase II as Topic; Fluoxetine; Humans; Migraine Disorders; Placebos; Selective Sero | 1999 |
Improvement of arthritis with fluoxetine.
Topics: Arthritis; Female; Fluoxetine; Humans; Middle Aged; Migraine Disorders; Pain; Selective Serotonin Re | 1992 |